Plasmacytoid Denditic Cells (pDC) in Multiple Sclerosis: IFN-β Treatment Inhibits pDC Secretion of Chemokines Specific for CCR5-Positive Th1 Cells

被引：0
作者：
Aung, Latt
Dhib-Jalbut, Suhayl
Balashov, Konstantin E.
机构：
[1] TEAGASC, Natl Food Ctr, Dublin 15, Ireland
[2] Univ Estadual Campinas, Paris 16, France
[3] Osaka Univ, Toyonaka, Osaka 560, Japan
[4] Kazakh Acad Sci, Alma Ata 480021, Kazakhstan
来源：
NEUROLOGY | 2010年 / 74卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A372 / A373
页数：2
相关论文
共 50 条
[31]   IFN-β-1b inhibits IL-12 production in peripheral blood mononuclear cells in an IL-10-dependent mechanism:: Relevance to IFN-β-1b therapeutic effects in multiple sclerosis [J].
Wang, X ;
Chen, M ;
Wandinger, KP ;
Williams, G ;
Dhib-Jalbut, S .
JOURNAL OF IMMUNOLOGY, 2000, 165 (01) :548-557
[32]   Interferon β1a Treatment Modulates TH1 Expression in γδ + T Cells from Relapsing-Remitting Multiple Sclerosis Patients [J].
Cerise L. Elliott ;
Samia Y. Ei-Touny ;
Mary L. Filipi ;
Kathleen M. Healey ;
M. Patricia Leuschen .
Journal of Clinical Immunology, 2001, 21 :200-209
[33]   IFN-β1a Inhibits the Secretion of Th17-Polarizing Cytokines in Human Dendritic Cells via TLR7 Up-Regulation [J].
Zhang, Xin ;
Jin, Jianping ;
Tang, Yunan ;
Speer, Danielle ;
Sujkowska, Danuta ;
Markovic-Plese, Silva .
JOURNAL OF IMMUNOLOGY, 2009, 182 (06) :3928-3936
[34]   High expression of cytotoxic molecules and Th1 bias of circulating T cells in patients with multiple sclerosis under fingolimod treatment [J].
Fujii, Chihiro ;
Okada, Yoichiro ;
Kimura, Kimitoshi ;
Nakagawa, Masanori ;
Matsumoto, Sadayuki ;
Takahashi, Ryosuke ;
Ochi, Hirofumi ;
Kondo, Takayuki ;
Mizuno, Toshiki .
JOURNAL OF NEUROIMMUNOLOGY, 2014, 275 (1-2) :199-199
[35]   Changes of percentages in immune cells phenotypes and cytokines production during two-year IFN-β-1a treatment in multiple sclerosis patients [J].
Dagmara Mirowska ;
Janusz Skierski ;
Aleksandra Paź ;
Mirosława Koronkiewicz ;
Jacek Zaborski ;
Jadwiga Kruszewska ;
Andrzej Członkowski ;
Anna Członkowska .
Journal of Neurology, 2003, 250 :1229-1236
[36]   Changes of percentages in immune cells phenotypes and cytokines production during two-year IFN-β-1a treatment in multiple sclerosis patients [J].
Mirowska, D ;
Skierski, J ;
Paz, A ;
Koronkiewicz, M ;
Zaborski, J ;
Kruszewska, J ;
Czlonkowski, A ;
Czlonkowska, A .
JOURNAL OF NEUROLOGY, 2003, 250 (10) :1229-1236
[37]   Interferon β1a treatment modulates TH1 expression in γδ plus T cells from relapsing-remitting multiple sclerosis patients [J].
Elliott, CL ;
Ei-Touny, SY ;
Filipi, ML ;
Healey, KM ;
Leuschen, MP .
JOURNAL OF CLINICAL IMMUNOLOGY, 2001, 21 (03) :200-209
[38]   CD4+T-cells counts and Th1/Th2 cytokine production after natalizumab treatment in multiple sclerosis patients [J].
Havrdova, E. ;
Mareckova, H. ;
Kovarova, I. ;
Krasulova, E. .
MULTIPLE SCLEROSIS, 2007, 13 :S168-S168
[39]   Alemtuzumab (Anti-CD52 mAb) Induces Expansion of Treg and Th2 Cells and Inhibits Th1 and Th17 Cells in Treated Patients with Relapsing Remitting Multiple Sclerosis (RRMS) [J].
Zhang, Xin ;
Tao, Yazhong ;
Chopra, Manisha ;
Troiani, Luigi ;
Marcus, Karen ;
Choudhary, Neelima ;
Wray, Sibyl ;
Krolczyk, Stanley ;
Markovic-Plese, Silva .
NEUROLOGY, 2012, 78
[40]   GRIM-19 Ameliorates Multiple Sclerosis in a Mouse Model of Experimental Autoimmune Encephalomyelitis with Reciprocal Regulation of IFNγ/Th1 and IL-17A/Th17 Cells [J].
Moon, Jeonghyeon ;
Lee, Seung Hoon ;
Lee, Seon-yeong ;
Ryu, Jaeyoon ;
Jhun, Jooyeon ;
Choi, JeongWon ;
Kim, Gyoung Nyun ;
Roh, Sangho ;
Park, Sung-Hwan ;
Cho, Mi-La .
IMMUNE NETWORK, 2020, 20 (05) :1-15
12345